Equities

Vo2 Cap Holding AB (publ)

Vo2 Cap Holding AB (publ)

Actions
TechnologyTechnology
  • Price (SEK)6.89
  • Today's Change-0.01 / -0.14%
  • Shares traded256.00
  • 1 Year change-72.15%
  • Beta0.6030
Data delayed at least 15 minutes, as of Sep 30 2022 17:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Vo2 Cap Holding AB (publ), formerly Curando Nordic AB, is a Sweden-based company, which is engaged in the media tech industry. The Company's business model consists of acquiring and refining entrepreneurial companies.

  • Revenue in SEK (TTM)377.53m
  • Net income in SEK-5.33m
  • Incorporated--
  • Employees--
  • Location
    Vo2 Cap Holding AB (publ)Fleminggatan 18STOCKHOLM 112 26SwedenSWE
  • Phone+46 46386741
  • Websitehttps://curando.se/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VO2:STO since
announced
Transaction
value
Livewrapped ABDeal completed21 Apr 202221 Apr 2022Deal completed-19.88%7.19m
Adprofit ABDeal completed22 Nov 202122 Nov 2021Deal completed-65.43%4.92m
Data delayed at least 15 minutes, as of Sep 30 2022 17:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Active Biotech AB publ0.00-57.33m254.29m11.00--12.90-----0.2525-0.25250.000.07440.00-------99.01-27.85-119.68-56.59-------472.29---76.420.2212---100.00---54.52------
Magle Chemoswed Holding AB133.88m9.12m257.04m--28.191.7511.761.920.84440.844412.4013.610.57280.57775.97--3.90--5.06--89.35--6.81--0.7295--0.2557---7.16--130.57------
SoftOx Solutions AS6.33m-67.60m274.54m----4.15--43.40-6.68-6.680.6186.290.0732--0.4637---78.20-44.89-95.77-54.35-----1,068.77-540.761.08-116.250.1873---19.69139.15-74.85------
Kancera AB0.00-51.52m281.28m7.00--2.96-----0.918-0.9180.001.690.00----0.00-39.19-68.54-43.09-86.44--92.88---5,941.59---115.850.00---100.00---12.80------
ISR Immune System Rgultn Hldg AB (publ)0.00-257.16m282.94m-----------3.65-3.650.00-2.390.00-------1,169.75-111.37---155.17-----------128,581.00---------152.98------
Arctic Bioscience AS24.36m-36.91m286.33m----0.919--11.76-1.50-1.500.986112.570.06910.62352.68---10.47---11.05--18.34---151.56--8.86-135.400.00--4.97---88.48------
Alligator Bioscience AB19.08m-162.82m290.29m49.00--1.51--15.22-1.27-1.270.12450.87220.0938--2.35414,673.90-80.03-33.26-98.19-36.20-----853.59-672.07----0.0967--197.40-25.981.09---58.36--
SenzaGen AB30.33m-30.94m291.19m16.00--2.97--9.60-1.26-1.261.244.070.28414.465.66---28.98-25.56-32.24-27.4763.32130.22-102.02-471.453.51--0.0092--93.7998.69-15.38---23.45--
Herantis Pharma Oyj0.00-113.79m336.06m----16.13-----0.8301-0.83010.000.11350.00-------110.52-65.71-198.51-79.09-----------6.650.7896-------39.49------
Vo2 Cap Holding AB (publ)377.53m-5.33m340.92m----1.9249.220.903-0.323-0.3239.093.611.93--12.51---2.72-31.87-3.80-57.9521.3726.64-1.41-19.29--5.260.1680--46,310.78185.46-246.86------
Lytix Biopharma AS0.00-52.59m362.67m----1.98-----1.33-1.330.004.490.00-------24.75---26.05--------------0.00--466.67---14.16------
Initiator Pharma A/S0.00-62.44m364.47m----11.99-----1.40-1.400.000.58160.00-------124.45-70.46-139.58-80.40------------0.4185-------142.20------
Mendus AB (publ)1.79m-116.61m368.49m34.00--0.6138--205.40-0.5836-0.58360.0093.010.0025--0.094359,800.00-16.00-23.81-16.48-26.35-----6,499.94-----31.270.0418-------49.48------
ExpreS2ion Biotech Holding AB10.66m-63.07m374.94m29.00--2.12--35.16-1.88-1.880.31964.710.0673--6.30463,652.20-39.81-45.28-42.68-54.175.6958.57-591.46-194.44----0.0255---10.04---38.51------
Vivesto AB21.56m-98.81m394.92m17.00--0.6399--18.32-0.2059-0.20590.04571.150.03051.1914.75979,954.60-13.99---16.32---2.38---458.31--6.51-23.070.0109--------------
Medivir AB15.74m-93.43m425.82m9.00--1.89--27.06-1.61-1.610.27054.040.0491--3.121,748,667.00-29.14-35.47-32.80-41.85-431.69-564.00-592.99-864.41---35.360.051--83.09-22.79-48.11------
Data as of Sep 30 2022. Currency figures normalised to Vo2 Cap Holding AB (publ)'s reporting currency: Swedish Krona SEK
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.